怀孕中的高血压疾病增加心肌梗塞的风险:一项基于人口的研究
Lisa E Vaughan1, Yoshihisa Kanaji2, Sonja Suvakov3
1Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
Journal of the American College of Cardiology
|November 6, 2024
概括
妊娠高血压疾病 (HDP) 的病史与早期冠状动脉疾病 (CAD) 和心肌梗塞风险增加有关. 这强调了管理非阻塞性冠状动脉疾病以及传统风险因素的重要性.
科学领域:
- 心血管医学 心血管医学
- 产科和妇科 产科和妇科
- 流行病学 流行病学
背景情况:
- 妊娠高血压障碍 (HDP) 影响女性的长期心血管健康.
- 有限的数据存在于冠状动脉解剖和病变类型在妇女与HDP历史.
- 了解HDP在早期冠状动脉疾病 (CAD) 中的作用至关重要.
研究的目的:
- 研究妊娠高血压疾病 (HDP) 作为早期冠状动脉疾病 (CAD) 的独特风险因素.
- 确定HDP病史与急性冠状动脉综合征 (ACS) 类型之间的关联,包括动脉硬性ACS和心肌梗塞与非阻塞性冠状动脉 (MINOCA).
主要方法:
- 一项基于人群的队列研究,对患有 CAD 的女性进行了冠状动脉血管造影.
- 使用年龄匹配的对照对象进行了比较.
- SYNTAX评分评估了CAD复杂性;MINOCA诊断需要临床急性心肌梗塞而没有阻塞性冠状动脉疾病.
主要成果:
- 患有HDP史的女性在CAD事件发生时更年轻 (中位数为64.8岁与71.8岁).
- HDP史显示与急性冠状动脉综合征 (ACS) 有着强烈的关联.
- 患有HDP病史的女性有更高的SYNTAX得分 (OR 2.28) 和MINOCA (OR 2.08) 的几率.
结论:
- 妊娠高血压疾病 (HDP) 的病史与冠状动脉疾病 (CAD) 的早期发病有关.
- HDP病史增加了心肌梗塞的未来风险,包括阻塞性和非阻塞性冠状动脉疾病.
- 强调需要早期检测和管理非阻塞性冠状动脉疾病的妇女与HDP历史.
相关概念视频
Mitral Valve Prolapse III: Nursing Management
5
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
5
Hypertension and Regulation of Blood Pressure
1.9K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K
Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
Disorders of the Autonomic Nervous System
573
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
573
Adrenergic Antagonists: ɑ and β-Receptor Blockers
407
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
407


